Warning letterFDA · May 18, 2018
Revibe, Inc. MARCS-CMS 553137, May 18, 2018
Named company: Revibe, Inc.
FDA has determined that these products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d).…
